Skip to main content
Clinical Trials/NCT04375241
NCT04375241
Completed
Not Applicable

Detection of Asymptomatic Atrial Fibrillation in Persons of 65 Year of Age or Older

Diagram B.V.1 site in 1 country2,168 target enrollmentJuly 2, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Diagram B.V.
Enrollment
2168
Locations
1
Primary Endpoint
Specificity of the mobile ECG device
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Although the condition itself is not life-threatening, the complications result in increased morbidity and mortality. AF is often asymptomatic and a considerable number of people suffering from AF are not aware of their condition. Unfortunately, a cerebral infarction is often the first clinical manifestation. The idea to screen subjects opportunistically for Asymptomatic Atrial Fibrillation (AAF) was infeasible until recently. However, with a recently-developed smartphone connected Mobile ECG Device (MED), this seems to be feasible after all.

The main objectives are:

  • To examine the feasibility of screening subjects of ≥65 years old for AAF.
  • To validate the smartphone connected MED as an AAF screening instrument for application in transmural care in the Netherlands.

Detailed Description

Study design: Prospective validation study.

Registry
clinicaltrials.gov
Start Date
July 2, 2018
End Date
April 30, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Diagram B.V.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥65 years
  • Is willing to give informed consent

Exclusion Criteria

  • Known medical history with Atrial Fibrillation
  • Not mental competent

Outcomes

Primary Outcomes

Specificity of the mobile ECG device

Time Frame: At screening

Sensitivity of the mobile ECG device

Time Frame: At screening

Study Sites (1)

Loading locations...

Similar Trials